Project Description

Inhalation therapy refers to the delivery of medications to or via the lungs (respiratory system). Avantika has been developing a portfolio of complex inhalation products such as dry powder inhalers (DPI), and metered dose inhalers (MDI) for the treatment of respiratory diseases. These products, particularly MDIs and DPIs, require a wide range of diverse functional requirements — particle size-driven formulation and process, complex device design, demonstration of equivalence to originator product, and pharmacokinetics and clinical endpoint studies. The product line also requires dedicated and precision manufacturing lines potentially unique to each product within this class, which Avantika has significantly invested in the last few years to develop these capabilities.